Today is the deadline for firms to lodge their quarterly reports. These are the small cap companies that stood out for the right — and wrong — reasons.


Imagion Biosystems (ASX:IBX) +10%

Many companies tackling cancer have a net cash outflow from operating activities. But a $2 million Research and Development windfall ensures Imagion is not one of them.

IBX’s breakthrough moment was its device designation from the FDA in July. It is is continuing negotiations to undertake a human study and consequently launched a capital raise a few days ago.

Marley Spoon (ASX:MMM) +15%

The subscription meal kit provider’s investors responded well to its quarterly.

While its net cash from operating activities was negative by 5.6 million euros ($9.1 million) Marley Spoon announced year to date revenue up 49 per cent and operating EBITDA improving from 31 per cent to 49 per cent.

Marley Spoon expects calendar 2019 revenue to be up 35-40 per cent, year on year.

Additionally, this morning it announced a $22 million debt capital raise agreed in principle with an unnamed Silicon Valley venture debt lender subject.

CEO Fabian Siegel told a conference call this morning,” Over the past year we’ve proven our business model in Australia and we are now seeing improvements to our profitability and growth”. He said he expected further growth as grocery behaviour shifted online.

New Zealand Coastal SeaFoods (ASX:NZS) + 14%

This stock used to be TV company XTV. That is until a delisting-avoiding reverse takeover with a New Zealand seafood company. Chairman Winton Willesee told Stockhead a bright future was ahead.

It is still early days for the company but customer cash receipts were double from a year ago to NZ$307,994 ($286,889).

NZS also announced new executive appointments, including a  head of sales and chief operating officer.

Also, it is moving to a new and upgraded seafood processing and production facility. This is 5 times larger than the existing site and closer to Christchurch airport.

BuildingIQ (ASX:BIQ) -36%

Before the last quarterly season here was The Secret Broker’s advice to Stockhead’s loyal readers.

Like Mrs Broker does with my wallet, I go straight to the cash balance and no matter what Mr Burns or Mrs Broker would like it to be, it is what it is.

Only after seeing this figure, will I start to work backwards and look at their next quarter estimated expenditure and then at any income received.

The business boasted about a 10 per cent cash receipt growth and 26 per cent fall in operating expenses. But arguably investors paid more attention to the Secret Broker considering the cash and cash equivalents figure.

CEO Michael Nark called the financial metrics ‘mixed’. He noted it has made cumulative savings for its customers of $5.15 million last quarter.

Read More:

The Secret Broker: Wednesday July 31 is Duck Soup Day